Mandate

Vinge has advised VARO Energy Marketing AG in its acquisition of Corral Petroleum Holdings AB, the parent company of the Preem group

Preem operates around 500 filling stations in Sweden, as well as refineries in Lysekil and Gothenburg which in total represent over 40% of Sweden’s energy needs for transportation and 80% of its refining capacity. Preem and Varo will jointly become Europe’s second largest renewable fuel producer and account for almost 10% of all road and marine fuels sold in Europe.

The transaction is subject to customary regulatory approvals.

 

Vinge's team primarily consisted of Samra Tesser, Peter Sundgren, Vilhelm Rondahl, Gustav Persson, Alexander Rüdén, Ian Linde and Matilda Hamner (M&A), Albert Wållgren, Linn Adelwald, Calle Tengwall Pagels and Karl-Gustaw Tobola (Banking & Finance), Johan Cederblad (Environmental Law), Martin Boström and Mario Saad (Corporate Commercial), Hanna Kövamees (Real Estate and Construction), Emil Lindwall and Agnes Pigg (Employment and Benefits), Daniel Wendelsson, Lovisa Lewin, Dagne Sabockis and Sara Hammond (Competition & Regulatory), Rebecka Målquist (IP), Carla Håkansson (IT), Gulestan Ali (Compliance) and Caroline Löv and Ellinore Boström Andersson (Transaction Support).

Related

Vinge has advised Egetis Therapeutics in connection with a directed share issue

Vinge has advised Egetis Therapeutics AB (publ) (“Egetis Therapeutics”), listed on Nasdaq Stockholm, in connection with a directed share issue whereby Egetis Therapeutics raised proceeds of approximately SEK 183 million before transaction costs.
October 06, 2025

Vinge worked with funds advised by Agilitas on the buy-out of Vivicta (previously Tietoevry Tech Services), including on the issuance of senior secured bonds and on entering into a super senior RCF

Vinge, together with O’Melveny as lead counsel and Avance, worked with funds advised by Agilitas Private Equity LLP (“Agilitas”), the pan-European mid-market private equity firm, in their backing of Vivicta. The buy-out was previously announced on 24 March 2025 and closed on 2 September 2025.
October 03, 2025

Vinge has advised Hansa Biopharma in connection with a directed share issue of approx. SEK 671.5 million

Vinge has advised Hansa Biopharma AB (publ) in connection with a directed share issue through which the company raises proceeds of approx. SEK 671.5 million before transaction costs.
October 03, 2025